Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Safety of Subcutaneous Administration of Rituximab during the First-Line Treatment of Patients with Non-Hodgkin Lymphoma: The MabRella Study

Carlos Panizo, Mohamed Amine Bekadja, Balkis Meddeb, Maria Rigoroso Mendoza, Matt Truman, Rodney Smith, Claudia Baratè

Blood (2016) 128 (22): 2971.

https://doi.org/10.1182/blood.V128.22.2971.2971

Published: 2016

Journal Articles

Depth of Response to ≥VGPR at Completion of Induction Influences Outcome Post ASCT, on Behalf of the Tunisian Myeloma Study Group

Blood (2016) 128 (22): 5827.

https://doi.org/10.1182/blood.V128.22.5827.5827

Published: 2016

Journal Articles

Hepatobiliary and Thromboembolic Events during Long-Term E.X.T.E.N.Ded Treatment with Eltrombopag in Adult Patients with Chronic Immune Thrombocytopenia (ITP)

Mansoor N. Saleh, James B Bussel, MD, Raymond SM Wong, Balkis Meddeb, Abdulgabar Salama, Ali El-Ali, Erhard Quebe-Fehling, PhD, Abderrahim Khelif

Blood (2016) 128 (22): 1368.

https://doi.org/10.1182/blood.V128.22.1368.1368

Published: 2016

Journal Articles

Efficacy of Eltrombopag in Adult East Asian and Non-East Asian Patients with Chronic Immune Thrombocytopenia (cITP): Results from the Extend Study

Raymond SM Wong, James B Bussel, MD, Mansoor N. Saleh, Abderrahim Khelif, Balkis Meddeb, Ali El-Ali, Erhard Quebe-Fehling, PhD, Abdulgabar Salama

Blood (2016) 128 (22): 4930.

https://doi.org/10.1182/blood.V128.22.4930.4930

Published: 2016

Journal Articles

Azacitidine (AZA) Combined with Idarubicin in Higher Risk MDS - Results of a Phase I/II Study By the Groupe Francophone Des Myelodysplasies (GFM)

Marie Sebert, MD, Aspasia Stamatoullas, MD, Thorsten Braun, MD PhD, Jacques Delaunay, MD, Benoît de Renzis, Ramzi Jeddi, MD, Balkis Meddeb, Mathilde Hunault Berger, Benedicte Samey, Fatiha Chermat, Sylvie Chevret, Cendrine Chaffaut, Pierre Fenaux, MD PhD, Lionel Ades, MD PhD

Blood (2015) 126 (23): 2884.

https://doi.org/10.1182/blood.V126.23.2884.2884

Published: 2015

Journal Articles

Chronic Myeloid Leukemia Patients In Tunisia: Epidemiology and Outcome In The Imatinib Era (A Multicentric Experience)

Raihane Ben Lakhal, Hela Ghedira, Hatem Bellaaj, Yosra Ben Youssef, Samia Menif, Zeineb Manai, Manel Bedoui, Amel Lakhal, Balkis Meddeb

Blood (2013) 122 (21): 4037.

https://doi.org/10.1182/blood.V122.21.4037.4037

Published: 2013

Journal Articles

Rituximab in Combination with Bendamustine or Chlorambucil for Treating Patients with Chronic Lymphocytic Leukemia: Interim Results of a Phase IIIb Study (MaBLe).

Veronique Leblond, Kamel Laribi, MD, Osman Ilhan, MD, Melih Aktan, Ali Unal, MD, Saad M B Rassam, MD, FRCP, FRCPath, Anna Schuh, MD, PhD, MRCP, FRCPath, Tom Widenius, MD, PhD, Peter Johansson, MD, PhD, Joao Raposo, Balkis Meddeb, Carol Moreno, MD, PhD, Stephan H.K. Oertel, MD, Anne-Sophie Michallet, MD, PhD

Blood (2012) 120 (21): 2744.

https://doi.org/10.1182/blood.V120.21.2744.2744

Published: 2012

Journal Articles

Adult ALL Patients Treated with Pediatric Inspired Trials Have Inacceptable Early Death but Better Relapse Free Survival Compared to Adult Trials: A Tunisian Single Center Experience

Hend Ben Neji, Yosr Ben Abdennebi, Lamia Aissaoui, Ramzi Jeddi, Mohamed Zarrouk, Ramzi Ben amor, Karima Kacem, Raihane Ben Lakhal, Zaher Belhadj Ali, Hela Ben Abid, Balkis Meddeb

Blood (2012) 120 (21): 4297.

https://doi.org/10.1182/blood.V120.21.4297.4297

Published: 2012

Journal Articles

Results with ATRA and Anthracycline Based Chemotherapy (CT) in Acute Promyelocytic Leukemia (APL) in a Developing Country. Should Dose Intensity Be Reduced to Obtain Acceptable Results?

Ramzi Jeddi, Hèla Ghédira, Hèla Stambouli, Ramzi Ben amor, Karima Kacem, MD, Yosr Ben Abdennebi, Mohamed Zarrouk, Hend Ben Neji, Raihane ben Lakhal, Lamia Aissaoui, Samia Menif, Emna Gouider, Hèla Ben Abid, Zaher Ben Hadjali, Pierre Fenaux, MD, PhD, Balkis Meddeb, MD

Blood (2011) 118 (21): 4271.

https://doi.org/10.1182/blood.V118.21.4271.4271

Published: 2011

Journal Articles

Human Platelet Alloantigens (HPA)1, HPA2 and HPA3 SNPs in Tunisian Sickle Cell Disease Patients

Adel Driss, PhD, MSc, BSc, Karima Kacem, MD, Nana Wilson, MPH, Jacqueline Hibbert, PhD, Tom Adamkiewicz, MD, MSCR, FRCP(C), Beatrice E Gee, MD, Balkis Meddeb, MD, Jonathan K Stiles, PhD

Blood (2011) 118 (21): 4852.

https://doi.org/10.1182/blood.V118.21.4852.4852

Published: 2011

Journal Articles

High Body Mass Index (BMI) as a Predictor of Differentiation Syndrome (DS) In Acute Promyelocytic Leukemia (APL).

Ramzi Jeddi, Béchir Achour, Agnès Guerci-Bresler, Héla Ghédira, Hervé Dombret, Françoise Huguet, Patrice Chevallier, Norbert Vey, Stephane de Botton, Dominique Bordessoule, Beatrice U. Muller, Virginie Eclache, Claude Gardin, Balkis Meddeb, Lionel Adès, Pierre Fenaux, MD, PhD

Blood (2010) 116 (21): 1078.

https://doi.org/10.1182/blood.V116.21.1078.1078

Published: 2010

Journal Articles

Predictive Factors of Severe Sepsis and Septic Shock in Patients with Hematological Malignancies and Pseudomonas Infections.

Ramzi Jeddi, Hèla Ghédira, Ramzi ben Amor, Lamia Aissaoui, Karima Kacem, Walid Bouterâa, Yosr ben Abdennebi, Raihane ben Lakhal, Amel Turki, Hèla ben Abid, Zaher Belhadjali, Balkis Meddeb

Blood (2009) 114 (22): 4552.

https://doi.org/10.1182/blood.V114.22.4552.4552

Published: 2009

Journal Articles

Long-Term Treatment of Chronic Immune Thrombocytopenic Purpura with Oral Eltrombopag: Results From the EXTEND Study.

Mansoor N. Saleh, MD, James B. Bussel, MD, Gregory Cheng, Balkis Meddeb, Bhabita Mayer, Christine Bailey, Manuel Aivado

Blood (2009) 114 (22): 682.

https://doi.org/10.1182/blood.V114.22.682.682

Published: 2009

Journal Articles

Eltrombopag Is Efficacious in Patients with Refractory Chronic Idiopathic Thrombocytopenic Purpura (ITP) - Data from the EXTEND Study

Mansoor N Saleh, James B Bussel, Gregory Cheng, Balkis Meddeb, Paul M Burgess, Maria E De Obaldia, Nicole L Stone, Manuel Aivado

Blood (2008) 112 (11): 401.

https://doi.org/10.1182/blood.V112.11.401.401

Published: 2008

Journal Articles

Oral Eltrombopag Treatment Reduces the Need for Concomitant Medications in Patients with Chronic Idiopathic Thrombocytopenic Purpura.

Patrick F. Fogarty, James B Bussel, Gregory Cheng, Mansoor N Saleh, Balkis Meddeb, Christine Bailey, Andres Brainsky

Blood (2008) 112 (11): 3424.

https://doi.org/10.1182/blood.V112.11.3424.3424

Published: 2008

Journal Articles

Eltrombopag Delivers Clinical Benefit in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients Not Achieving Platelet Counts ≥50,000/μL - Data from the EXTEND Study.

Gregory Cheng, James B Bussel, Mansoor N Saleh, Balkis Meddeb, Maria E De Obaldia, Manuel Aivado, Nicole L Stone

Blood (2008) 112 (11): 3430.

https://doi.org/10.1182/blood.V112.11.3430.3430

Published: 2008

Journal Articles

Safety and Efficacy of Long-Term Treatment with Oral Eltrombopag for Chronic Idiopathic Thrombocytopenic Purpura.

James B Bussel, Gregory Cheng, Mansoor N Saleh, Balkis Meddeb, Christine Bailey, Nicole L Stone, Manuel Aivado

Blood (2008) 112 (11): 3432.

https://doi.org/10.1182/blood.V112.11.3432.3432

Published: 2008

Journal Articles

Long-Term Safety and Efficacy of Oral Eltrombopag for the Treatment of Subjects with Idiopathic Thrombocytopenic Purpura (ITP): Preliminary Data from the EXTEND Study.

James B. Bussel, MD, Gregory Cheng, MD, Lidia Kovaleva, MD, Mansoor N. Saleh, MD, Balkis Meddeb, MD, Bhabita Mayer, PhD, J. Lee Fraser, PhD, Manuel Aivado, MD

Blood (2007) 110 (11): 566.

https://doi.org/10.1182/blood.V110.11.566.566

Published: 2007

NARROW

Safety of Subcutaneous Administration of Rituximab during the First-Line Treatment of Patients with Non-Hodgkin Lymphoma: The MabRella Study

Depth of Response to ≥VGPR at Completion of Induction Influences Outcome Post ASCT, on Behalf of the Tunisian Myeloma Study Group

Hepatobiliary and Thromboembolic Events during Long-Term E.X.T.E.N.Ded Treatment with Eltrombopag in Adult Patients with Chronic Immune Thrombocytopenia (ITP)

Efficacy of Eltrombopag in Adult East Asian and Non-East Asian Patients with Chronic Immune Thrombocytopenia (cITP): Results from the Extend Study

Azacitidine (AZA) Combined with Idarubicin in Higher Risk MDS - Results of a Phase I/II Study By the Groupe Francophone Des Myelodysplasies (GFM)

Chronic Myeloid Leukemia Patients In Tunisia: Epidemiology and Outcome In The Imatinib Era (A Multicentric Experience)

Rituximab in Combination with Bendamustine or Chlorambucil for Treating Patients with Chronic Lymphocytic Leukemia: Interim Results of a Phase IIIb Study (MaBLe).

Adult ALL Patients Treated with Pediatric Inspired Trials Have Inacceptable Early Death but Better Relapse Free Survival Compared to Adult Trials: A Tunisian Single Center Experience

Results with ATRA and Anthracycline Based Chemotherapy (CT) in Acute Promyelocytic Leukemia (APL) in a Developing Country. Should Dose Intensity Be Reduced to Obtain Acceptable Results?

Human Platelet Alloantigens (HPA)1, HPA2 and HPA3 SNPs in Tunisian Sickle Cell Disease Patients

High Body Mass Index (BMI) as a Predictor of Differentiation Syndrome (DS) In Acute Promyelocytic Leukemia (APL).

Predictive Factors of Severe Sepsis and Septic Shock in Patients with Hematological Malignancies and Pseudomonas Infections.

Long-Term Treatment of Chronic Immune Thrombocytopenic Purpura with Oral Eltrombopag: Results From the EXTEND Study.

Eltrombopag Is Efficacious in Patients with Refractory Chronic Idiopathic Thrombocytopenic Purpura (ITP) - Data from the EXTEND Study

Oral Eltrombopag Treatment Reduces the Need for Concomitant Medications in Patients with Chronic Idiopathic Thrombocytopenic Purpura.

Eltrombopag Delivers Clinical Benefit in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients Not Achieving Platelet Counts ≥50,000/μL - Data from the EXTEND Study.

Safety and Efficacy of Long-Term Treatment with Oral Eltrombopag for Chronic Idiopathic Thrombocytopenic Purpura.

Long-Term Safety and Efficacy of Oral Eltrombopag for the Treatment of Subjects with Idiopathic Thrombocytopenic Purpura (ITP): Preliminary Data from the EXTEND Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only